134 related articles for article (PubMed ID: 25419181)
1. Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study.
Huang J; Wai ES; Lau F; Blood PA
BMC Palliat Care; 2014; 13(1):49. PubMed ID: 25419181
[TBL] [Abstract][Full Text] [Related]
2. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.
Kong W; Jarvis C; Mackillop WJ
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):83-91. PubMed ID: 25481789
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing access to palliative radiotherapy: a Norwegian population-based study.
Åsli LM; Myklebust TÅ; Kvaløy SO; Jetne V; Møller B; Levernes SG; Johannesen TB
Acta Oncol; 2018 Sep; 57(9):1250-1258. PubMed ID: 29706109
[TBL] [Abstract][Full Text] [Related]
4. Inequities in Access: How Utilization of Palliative Radiation Therapy in British Columbia Varies with Geography.
French J; McGahan C; Duncan G; Chu C; Soo J; Lengoc S
J Med Imaging Radiat Sci; 2008 Jun; 39(2):75-80. PubMed ID: 31051806
[TBL] [Abstract][Full Text] [Related]
5. Referral Patterns of Patients for Palliative Radiation Therapy in British Columbia: A Comparison Between Rural and Urban Family Physicians.
Lengoc S; Soo J; McGahan CE; French J; Tyldesley S; Olson R
J Med Imaging Radiat Sci; 2012 Sep; 43(3):161-167. PubMed ID: 31051895
[TBL] [Abstract][Full Text] [Related]
6. Palliative radiotherapy for women with breast cancer.
Danielson B; Winget M; Gao Z; Murray B; Pearcey R
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):506-12. PubMed ID: 18524556
[TBL] [Abstract][Full Text] [Related]
7. Utilization of palliative radiotherapy for bone metastases near end of life in a population-based cohort.
Tiwana MS; Barnes M; Kiraly A; Olson RA
BMC Palliat Care; 2016 Jan; 15():2. PubMed ID: 26748495
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the use of palliative radiotherapy in Ontario.
Huang J; Zhou S; Groome P; Tyldesley S; Zhang-Solomans J; Mackillop WJ
J Clin Oncol; 2001 Jan; 19(1):137-44. PubMed ID: 11134206
[TBL] [Abstract][Full Text] [Related]
9. Estimating the need for palliative radiotherapy for non-small cell lung cancer: A criterion-based benchmarking approach.
Jin CJ; Kong W; Mackillop WJ
Radiother Oncol; 2018 Sep; 128(3):541-547. PubMed ID: 29934108
[TBL] [Abstract][Full Text] [Related]
10. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study.
Lavergne MR; Johnston GM; Gao J; Dummer TJ; Rheaume DE
Palliat Med; 2011 Mar; 25(2):101-10. PubMed ID: 20937613
[TBL] [Abstract][Full Text] [Related]
11. Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, Canada.
Merchant SJ; Kong W; Mahmud A; Booth CM; Hanna TP
J Palliat Care; 2023 Apr; 38(2):157-166. PubMed ID: 35043749
[TBL] [Abstract][Full Text] [Related]
12. Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life.
Goodridge D; Lawson J; Rennie D; Marciniuk D
Rural Remote Health; 2010; 10(2):1349. PubMed ID: 20438281
[TBL] [Abstract][Full Text] [Related]
13. Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.
Mackillop WJ; Kong W
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):51-59. PubMed ID: 26700702
[TBL] [Abstract][Full Text] [Related]
14. Variations in intensity of end-of-life cancer therapy by cancer type at a Canadian tertiary cancer centre between 2003 and 2010.
Grendarova P; Sinnarajah A; Trotter T; Card C; Wu JS
Support Care Cancer; 2015 Oct; 23(10):3059-67. PubMed ID: 25744287
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.
Angelo K; Norum J; Dalhaug A; Pawinski A; Aandahl G; Haukland E; Engljähringer K; Nieder C
Anticancer Res; 2014 Feb; 34(2):877-85. PubMed ID: 24511026
[TBL] [Abstract][Full Text] [Related]
16. Geographical distance and reduced access to palliative radiotherapy: systematic review and meta-analysis.
Chand CP; Greenley S; Macleod U; Lind M; Barton R; Kelly C
BMJ Support Palliat Care; 2022 Mar; ():. PubMed ID: 35292512
[TBL] [Abstract][Full Text] [Related]
17. Quality of end-of-life cancer care in Canada: a retrospective four-province study using administrative health care data.
Barbera L; Seow H; Sutradhar R; Chu A; Burge F; Fassbender K; McGrail K; Lawson B; Liu Y; Pataky R; Potapov A
Curr Oncol; 2015 Oct; 22(5):341-55. PubMed ID: 26628867
[TBL] [Abstract][Full Text] [Related]
18. Survival after palliative radiotherapy in geriatric cancer patients.
Nieder C; Angelo K; Haukland E; Pawinski A
Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
[TBL] [Abstract][Full Text] [Related]
19. Use of Radiation Therapy Within the Last Year of Life Among Cancer Patients.
Tseng YD; Gouwens NW; Lo SS; Halasz LM; Spady P; Mezheritsky I; Loggers E
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):21-29. PubMed ID: 29487025
[TBL] [Abstract][Full Text] [Related]
20. An Analysis of Clinical and Systemic Factors Associated with Palliative Radiotherapy Delivery and Completion at the End of Life in Alberta, Canada.
Goutam S; Ghosh S; Stosky J; Tam A; Quirk S; Fairchild A; Wu J; Kerba M
Curr Oncol; 2023 Nov; 30(12):10043-10056. PubMed ID: 38132364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
